telemetry into actionable insights, predicting injury risks, optimizing performance, accelerating drug discovery, and providing critical data to first responders during emergencies.

Meditech BioLink is architecting the future of biological intelligence by moving healthcare from a reactive model to a continuous, predictive ecosystem. The platform anchors fragmented biological data—from labs, wearables, and hospitals—to a Unified Digital Twin, a real-time, evolving virtual model of the user.

The BioLink ecosystem operates on three layers:

Ingestion: Hardware-agnostic aggregation from Meditech devices (Watch, Ring, Smart Pill) and third-party integrations (Apple, Oura). Twin Engine: A real-time processing core that normalizes data streams. Intelligence Layer: Specialized AI modules tailored to specific market segments.

Key Modules include:

AthleTwin (Sports): Injury prediction and readiness scoring for elite athletes. HumaTwin (Enterprise): Ergonomic monitoring and "Fit-for-Duty" compliance for workforce safety. TraumaTwin (Public Safety): Critical data access (NFC override) for EMS and first responders. Helix & Synth: High-performance pharmacogenomics and generative R&D engines designed to revolutionize drug discovery. These tools allow pharmaceutical partners to simulate biological interactions, de-risk clinical trials through precision patient stratification, and predict therapeutic outcomes before physical testing.

Meditech BioLink serves B2B Enterprise clients (Fortune 500s), Professional Sports Leagues, Pharmaceutical Researchers, and Government/Public Health sectors.